Cost analysis of rapid diagnostics for drug-resistant tuberculosis
Background Growth-based drug susceptibility testing (DST) is the reference standard for
diagnosing drug-resistant tuberculosis (TB), but standard time to result (TTR) is typically≥ 3 …
diagnosing drug-resistant tuberculosis (TB), but standard time to result (TTR) is typically≥ 3 …
A field evaluation of the Hardy TB MODS Kit™ for the rapid phenotypic diagnosis of tuberculosis and multi-drug resistant tuberculosis
L Martin, J Coronel, D Faulx, M Valdez, M Metzler… - PloS one, 2014 - journals.plos.org
Background Even though the WHO-endorsed, non-commercial MODS assay offers rapid,
reliable TB liquid culture and phenotypic drug susceptibility testing (DST) at lower cost than …
reliable TB liquid culture and phenotypic drug susceptibility testing (DST) at lower cost than …
Epidemiological burden of tuberculosis in develo** countries
DM Castañeda-Hernández… - Curr. Top. Public …, 2013 - books.google.com
Tuberculosis (TB) is an infectious disease caused by different species of the genus
Mycobacte‐-ria. Together with human immunodeficiency virus infection (HIV)/Acquired …
Mycobacte‐-ria. Together with human immunodeficiency virus infection (HIV)/Acquired …
A user-friendly, open-source tool to project impact and cost of diagnostic tests for tuberculosis
Most models of infectious diseases, including tuberculosis (TB), do not provide results
customized to local conditions. We created a dynamic transmission model to project TB …
customized to local conditions. We created a dynamic transmission model to project TB …
Effect of universal MODS access on pulmonary tuberculosis treatment outcomes in new patients in Peru
A Mendoza-Ticona, E Alarcón, V Alarcón… - Public Health …, 2012 - ingentaconnect.com
SETTING: Primary health care centres in Callao, Peru. OBJECTIVES: To evaluate the effect
of universal access to the microscopic-observation drug susceptibility (MODS) assay on …
of universal access to the microscopic-observation drug susceptibility (MODS) assay on …
A suggested algorithm for detection of multi drug-resistant tuberculosis in Zimbabwe: MDR-TB detection in resource limited settings
B Makamure, S Makumbirofa, T Bandason… - The Journal of Infection …, 2017 - jidc.org
Introduction: Rapid genotypic and phenotypic methods for multi-drug-resistant-tuberculosis
(MDR-TB) detection are now widely available. Zimbabwe adopted the use of GeneXpert …
(MDR-TB) detection are now widely available. Zimbabwe adopted the use of GeneXpert …
Diagnosis and Treatment of Multidrug-Resistant Tuberculosis in Developed and Develo** Countries: Finally Towards Equality?
R Laniado-Laborín, D J. Palmero… - Current Respiratory …, 2012 - benthamdirect.com
Tuberculosis TB is considered a sobering example of inequity. It is a disease predominantly
of the socially and economically disadvantaged. This neglect is evidenced by lack of political …
of the socially and economically disadvantaged. This neglect is evidenced by lack of political …
[PDF][PDF] DEVELOPMENT OF A TEST ASSOCIATED WITH MAGNETIC NANOPARTICLES FOR THE DIAGNOSIS OF TUBERCULOSIS.
NL JANAMPA - repositorio.upch.edu.pe
Tuberculosis (TB) is an infectious disease caused by Mycobacterium tuberculosis (MTB),
transmitted orally-respiratory and mainly affects the lungs, leading to an intense cough, fever …
transmitted orally-respiratory and mainly affects the lungs, leading to an intense cough, fever …
[PDF][PDF] TÜBERKÜLOZDA HIZLI MOLEKÜLER TANI TESTLERİ
R DURMAZ - ankemdernegi.org.tr
Drug resistance in tuberculosis (TB) is a matter of grave concern for TB control programs.
Accurate and rapid identification of resistance are important to avoid nosocomial and …
Accurate and rapid identification of resistance are important to avoid nosocomial and …
Development of a test associated with magnetic nanoparticles for the diagnosis of tuberculosis.
NL Janampa - 2019 - theses.hal.science
Mycobacterium tuberculosis causes one of the diseases with the highest mortality and
morbidity rate in the Americas and around the world. In develo** countries, the diagnosis …
morbidity rate in the Americas and around the world. In develo** countries, the diagnosis …